Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pyridium for Post-Sling Urinary Retention
NCT03302936Phase 4Completed
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Start
- Oct 2017
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of phenazopyridine in urinary retention, sponsored by Icahn School of Medicine at Mount Sinai. Started Oct 2017; status: completed.
02
Drugs
phenazopyridine
03
Conditions
urinary retention
Beyond the preview
Go deeper on NCT03302936.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03302936.